|
Market Closed -
Toronto S.E.
05:24:57 17/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.4150 CAD | +1.22% |
|
-9.78% | -8.79% |
| 28/08 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 21/08 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 41.5x | - | -0.21x | 1.56x | 19.41x | 45.55x | - | 51.84M | ||
| 15.63x | 1.41x | 1.51x | 0.6x | 8.91x | 9.7x | -.--% | 13.95B | ||
| 16.16x | 1.67x | 1.55x | 0.72x | 7.53x | 9.44x | 2.31% | 6.33B | ||
| 19.37x | 2.15x | 2.52x | 0.71x | 12.02x | 12.25x | 1.3% | 6.01B | ||
| 14.56x | 2.15x | 1.03x | 0.89x | 6.23x | 8.34x | 2.9% | 4.09B | ||
| 14.21x | 4.28x | 289.19x | 1.22x | 7.47x | 13.95x | 5.69% | 3.14B | ||
| 13.98x | 2.65x | 0.67x | 0.59x | 4.55x | 7.49x | 5.17% | 3.09B | ||
| 37.9x | - | 0.66x | - | - | - | - | 2.95B | ||
| 13.18x | 5.92x | 2.3x | 0.78x | 5.88x | 8.18x | 4.93% | 2.73B | ||
| 18.68x | 3.27x | 0.81x | 0.56x | 7.12x | 11.66x | 2.17% | 1.38B | ||
| -111.45x | 2.31x | 1.5x | 0.39x | 14.06x | 50.67x | 0.02% | 1.28B | ||
| 13.74x | 0.83x | 0.19x | 0.28x | 2.64x | 6.77x | 3.34% | 924M | ||
| 19.81x | 2.33x | -0.4x | 0.81x | 7.48x | 17.8x | 6.23% | 849M | ||
| 38.37x | 3.66x | -5.9x | 0.89x | 11.14x | 21.94x | - | 822M | ||
| 27.26x | 7.43x | 1.01x | 0.99x | 13.45x | 20.85x | 1.31% | 811M | ||
| Average | 12.86x | 3.08x | 19.76x | 0.79x | 9.14x | 17.47x | 2.95% | 3.23B | |
| Weighted average by Cap. | 14.46x | 2.40x | 20.01x | 0.71x | 8.38x | 11.70x | 2.11% |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















